VALANX Biotech's Convertible Note Round

VALANX Biotech raised a round of funding on August 17, 2017.

VALANX Biotech is a university spin out offering a patented method for high-efficiency protein conjugation for cancer drug targeting and other uses.…

Articles about VALANX Biotech's Convertible Note Round: